CN113265414A - Construction method for converting high-yield bacterial strain of fengycin by using glucose - Google Patents
Construction method for converting high-yield bacterial strain of fengycin by using glucose Download PDFInfo
- Publication number
- CN113265414A CN113265414A CN202110560598.XA CN202110560598A CN113265414A CN 113265414 A CN113265414 A CN 113265414A CN 202110560598 A CN202110560598 A CN 202110560598A CN 113265414 A CN113265414 A CN 113265414A
- Authority
- CN
- China
- Prior art keywords
- gene
- strain
- sfp
- degq
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010002015 fengycin Proteins 0.000 title claims abstract description 30
- CUOJDWBMJMRDHN-VIHUIGFUSA-N fengycin Chemical compound C([C@@H]1C(=O)N[C@H](C(=O)OC2=CC=C(C=C2)C[C@@H](C(N[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(N)=O)C(=O)N1)[C@@H](C)O)=O)NC(=O)[C@@H](CCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)C[C@H](O)CCCCCCCCCCCCC)[C@@H](C)CC)C1=CC=C(O)C=C1 CUOJDWBMJMRDHN-VIHUIGFUSA-N 0.000 title claims abstract description 30
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 21
- 239000008103 glucose Substances 0.000 title claims abstract description 21
- 238000010276 construction Methods 0.000 title claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 24
- 241000276408 Bacillus subtilis subsp. subtilis str. 168 Species 0.000 claims abstract description 21
- 101150011645 cypC gene Proteins 0.000 claims abstract description 20
- 101150085919 degQ gene Proteins 0.000 claims abstract description 17
- 238000000855 fermentation Methods 0.000 claims abstract description 15
- 230000004151 fermentation Effects 0.000 claims abstract description 15
- 101150056746 sfp gene Proteins 0.000 claims abstract description 15
- 241000023308 Acca Species 0.000 claims abstract description 12
- 230000002503 metabolic effect Effects 0.000 claims abstract description 10
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 10
- 230000014509 gene expression Effects 0.000 claims abstract description 7
- 241000003114 Bacillus velezensis FZB42 Species 0.000 claims abstract description 6
- 230000002018 overexpression Effects 0.000 claims abstract description 5
- 239000002773 nucleotide Substances 0.000 claims description 31
- 125000003729 nucleotide group Chemical group 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 27
- 239000013612 plasmid Substances 0.000 claims description 23
- 101150046124 accA gene Proteins 0.000 claims description 19
- 101150091570 gapA gene Proteins 0.000 claims description 19
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 101150039774 GAPA1 gene Proteins 0.000 claims description 14
- 101100135734 Haloferax mediterranei (strain ATCC 33500 / DSM 1411 / JCM 8866 / NBRC 14739 / NCIMB 2177 / R-4) pccB gene Proteins 0.000 claims description 14
- 101100282114 Pseudomonas aeruginosa (strain UCBPP-PA14) gap2 gene Proteins 0.000 claims description 14
- 101150008263 accD gene Proteins 0.000 claims description 14
- 101150073818 gap gene Proteins 0.000 claims description 14
- 238000010353 genetic engineering Methods 0.000 claims description 8
- 238000003208 gene overexpression Methods 0.000 claims description 6
- 239000001888 Peptone Substances 0.000 claims description 5
- 108010080698 Peptones Proteins 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 5
- 235000019319 peptone Nutrition 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 4
- 238000001976 enzyme digestion Methods 0.000 claims description 4
- 230000004060 metabolic process Effects 0.000 claims description 4
- 238000012217 deletion Methods 0.000 claims description 3
- 230000037430 deletion Effects 0.000 claims description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 3
- 229910052564 epsomite Inorganic materials 0.000 claims description 3
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 3
- 238000005457 optimization Methods 0.000 claims description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 claims description 2
- 230000004907 flux Effects 0.000 claims description 2
- 230000001502 supplementing effect Effects 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 230000003321 amplification Effects 0.000 description 15
- 238000003199 nucleic acid amplification method Methods 0.000 description 15
- 239000007788 liquid Substances 0.000 description 13
- 244000063299 Bacillus subtilis Species 0.000 description 12
- 235000014469 Bacillus subtilis Nutrition 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 12
- 239000006228 supernatant Substances 0.000 description 11
- 239000012634 fragment Substances 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 238000012795 verification Methods 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000008223 sterile water Substances 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 108050009160 DNA polymerase 1 Proteins 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 239000000592 Artificial Cell Substances 0.000 description 2
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 239000006004 Quartz sand Substances 0.000 description 2
- 241000202758 Scirpus Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 241000840267 Moma Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108010019477 S-adenosyl-L-methionine-dependent N-methyltransferase Proteins 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006154 adenylylation Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 108010000785 non-ribosomal peptide synthase Proteins 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 229930001118 polyketide hybrid Natural products 0.000 description 1
- 125000003308 polyketide hybrid group Chemical group 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1288—Transferases for other substituted phosphate groups (2.7.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y604/00—Ligases forming carbon-carbon bonds (6.4)
- C12Y604/01—Ligases forming carbon-carbon bonds (6.4.1)
- C12Y604/01002—Acetyl-CoA carboxylase (6.4.1.2)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides a construction method for transforming a high-yield bacterial strain of fengycin by using glucose, which comprises the steps of connecting a P43 promoter gene and a degQ gene from bacillus subtilis 168 in series with a sfp gene from bacillus amyloliquefaciens FZB42 to form a gene expression module pHP13-P43-sfp-degQ, and transferring the module into an original bacterial strain of the bacillus subtilis 168 to obtain a bacterial strain cell BSP000 for synthesizing the fengycin. Three overexpression target genes of accA, cypC and gapA are predicted by constructing a BSP000 strain genome scale metabolic network model, and the three genes are overexpressed in the BSP000 strain to obtain the fenggen high-yield engineering strain BSP003, wherein the fermentation yield of the fenggen reaches 59.87mg/L, and is increased by 126% compared with an artificial strain BSP 000. Has practical application value for realizing the industrial production of the fengyuan.
Description
Technical Field
The invention belongs to the technical field of bacillus subtilis genetic engineering, and particularly relates to a method for constructing a genetic engineering strain capable of synthesizing fengyuan by using glucose by carrying out serial co-expression on sfp gene degQ genes, and finally realizing the improvement of the yield of the fengyuan of the engineering strain by simulating a target gene for overexpression by using a model.
Background
Lignocellulose is an abundant renewable resource on the earth at present, and five-carbon sugars such as arabinose and xylose and six-carbon sugars such as glucose and galactose can be generated after hydrolysis. The lignocellulose is comprehensively treated and utilized by a biological method, which is beneficial to solving the environmental problem.
Strains which utilize glucose to convert fengycin, such as Bacillus amyloliquefaciens LPB-18N (CN201911402559.6), are currently found in nature. However, the lignocellulosic hydrolysate is complex in composition and therefore needs to be treated using a multi-flora cell system. The following research on transforming the artificial cell of the fengycin with glucose is necessary, which is the starting point for the research on the interrelation of the multiple artificial cell populations.
The biological activity of the plumping element is equivalent to that of partial chemical pesticide, and the plumping element can obviously inhibit the growth of plant fungi, but has no obvious inhibiting effect on yeast and bacteria. Non-ribosomal peptide antibiotics like fengycin generally have unique biological activity functions, and can help microorganisms producing the antibiotics to better adapt to living environments, especially inhibit or kill opponents when encountering competition with other fungi or bacteria for survival, thereby greatly improving the self-competition capability. In recent years, a lot of researchers have made a lot of studies on the bacteriostatic activity of fengyuan by many scholars at home and abroad, and fengyuan has very wide application in the aspects of effectively preventing and treating plant diseases and the like (CN 201810540353.9).
A Fenogen synthetic gene cluster in the bacillus subtilis shares the same promoter pfen, the synthetic gene cluster comprises five coding genes which are sequentially arranged according to the sequence of fenC, fenD, fenE, fenA and fenB, each coding gene can code one subunit to realize a specific catalytic function, the sequential action of the five subunits can realize the synthesis of one Fenogen molecule, and the total length of a gene cluster sequence is 38.7 kb. The fengycin molecule is composed of two parts of a beta-fatty acid chain and a peptide ring, wherein the synthesis of the polypeptide part is different from the synthesis of common polypeptide, and the fengycin molecule is synthesized by non-ribosomal peptide synthetase which comprises a plurality of functional modules, such as an adenylation structural domain A, a condensation structural domain C, peptide acyl carrier protein PCP and the like.
Although fengycin has good antifungal activity, the yield is greatly limited, so many researchers have conducted various researches to improve the final yield of the strain fengycin, for example, ruu et al can improve the yield of fengycin by 72% (CN201911399328.4) by constructing gene knockout mutants. By adding K into fermentation medium of the fengycin+、Mg2+、Fe2+、Mn2+The results of the metal elements show that the biomass of the bacillus subtilis is obviously improved, and the yield of the fengyuan is also obviously improved.
Glucose is used as an important hydrolysate of lignocellulose, and the effective utilization of glucose has very important significance on the degradation of the lignocellulose. The Chassis cell Bacillus subtilis 168 strain can grow by using glucose, but can not synthesize the target product plumogen.
Disclosure of Invention
In order to solve the problems in the prior art, the invention constructs the bacillus subtilis strain capable of synthesizing the fengyuan by using glucose, designs a genome scale metabolic network model aiming at the problem of low yield of the fengyuan of the strain, and carries out genetic engineering modification on the strain under the guidance of the genome scale metabolic network model so as to improve the yield of the fengyuan.
The gene expression module pHP13-P43-sfp-degQ is formed by connecting a P43 promoter gene (the nucleotide sequence of which is shown as SEQ ID NO: 1) from bacillus subtilis 168, a degQ gene (the nucleotide sequence of which is shown as SEQ ID NO: 3) and a sfp gene (the nucleotide sequence of which is shown as SEQ ID NO: 2) from bacillus amyloliquefaciens FZB42 in series by using a genetic engineering technology, and the module is transferred into an original strain of the bacillus subtilis 168 by a chemical transformation method to obtain an artificial strain BSP000 capable of synthesizing the fengycin. In order to improve the yield of the bacterial strain for synthesizing the toyoxin, three overexpression target genes of accA gene (the nucleotide sequence of which is shown as SEQ ID NO: 5), cypC gene (the nucleotide sequence of which is shown as SEQ ID NO: 6) and gapA gene (the nucleotide sequence of which is shown as SEQ ID NO: 7) are predicted by constructing a bacterial strain genome scale metabolic network model, and the yield of the bacterial strain toyoxin is greatly promoted by overexpressing the three genes in a BSP000 bacterial strain, so that the high-yield engineering bacterial strain BSP003 of the toyoxin is obtained.
The purpose of the invention is realized by the following technical scheme:
a construction method for converting a high-yield bacterial strain of fengycin by using glucose; a bacillus subtilis 168 modified strain with excellent performance is successfully constructed by utilizing a synthetic biology method, and can synthesize the fengycin by utilizing glucose. A bacillus subtilis genome scale metabolic network model aiming at the production of the fengyuan is constructed. The gene modification of the bacillus subtilis is guided according to the constructed model simulation prediction, so that the synthesis capacity of the fengyuan of the bacillus subtilis is improved, the blindness of determining a target gene in the gene modification process is greatly reduced, the experimental amount is reduced, and the efficiency of synthesizing the fengyuan by modifying the bacillus subtilis in metabolic engineering is improved.
A construction method for converting a high-yield bacterial strain of fengycin by using glucose; comprises the following steps
1) Designing PCR primers according to the known sequence of the P43 promoter gene, and amplifying the P43 promoter gene by taking the Bacillus subtilis 168 genome as a template;
2) designing a PCR primer according to the known sequence of the sfp gene, and amplifying the sfp gene by using a bacillus amyloliquefaciens FZB42 genome as a template;
3) designing a PCR primer according to the known sequence of the degQ gene, and amplifying the gene degQ by taking a bacillus subtilis 168 genome as a template;
4) connecting a P43 promoter gene, an sfp gene and a degQ gene with pHP13 plasmid in series through enzyme digestion to form a gene expression module pHP 13-P43-sfp-degQ;
5) transferring the recombinant gene expression module pHP13-P43-sfp-degQ constructed in the step 4) into an original strain of the bacillus subtilis 168 by a chemical conversion method to construct a strain BSP000 capable of synthesizing the fengycin by using glucose;
6) aiming at the BSP000 strain, collecting all gene-protein-reaction information of the strain from a database, and constructing a genome scale network metabolic model of the BSP000 strain after optimization such as supplementing deletion reaction, removing redundant reaction and the like;
7) calculating the network metabolism model constructed in the step 6) by using flux balance analysis and a minimum metabolism regulation algorithm to obtain three overexpression target genes of accA, cypC and gapA;
8) designing PCR primers according to known sequences of accA, cypC and gapA genes, and amplifying the genes accA, cypC and gapA by taking a bacillus subtilis 168 genome as a template;
9) the genes accA, cypC and gapA are connected with pHY300PLK plasmid in series through enzyme digestion to form a gene over-expression vector pHY300 ACG;
10) transferring the gene over-expression vector pHY300ACG constructed in the step 9) into a BSP000 strain by a chemical conversion method to obtain a BSP003 strain;
11) carrying out shake flask fermentation culture on the genetic engineering strain constructed in the step 10) by using a fermentation medium, and efficiently producing the fengyuan.
The nucleotide sequence of the promoter gene of P43 is SEQ ID NO. 1.
The nucleotide sequence of the sfp gene is SEQ ID NO. 2.
The nucleotide sequence of the degQ gene is SEQ ID NO. 3.
The pHP13 plasmid nucleotide sequence is SEQ ID NO: 4.
The nucleotide sequence of the accA gene is SEQ ID NO. 5.
The nucleotide sequence of the cypC gene is SEQ ID NO. 6.
The nucleotide sequence of the gapA gene is SEQ ID NO. 7.
The pHY300PLK plasmid nucleotide sequence is SEQ ID NO 8.
The fermentation medium is as follows: glucose 20g/L, peptone 20g/L, MgSO4·7H2O 0.5g/L,Na2HPO4·2H2O 0.4g/L,NaH2PO4 0.154g/L,pH 7.2~7.4。
And (3) carrying out shake-flask fermentation culture on the constructed genetic engineering strain by using a fermentation culture medium, and efficiently producing the fengyuan.
The method can ensure that the bacillus subtilis 168 has the ability of synthesizing the fengyuan, the yield of the fengyuan is 26.44mg/L, a genome scale network metabolic model of a BSP000 strain is constructed for improving the synthesis of the fengyuan, and a target gene target is predicted to be subjected to genetic engineering transformation, so that the yield of the fengyuan is improved to 59.87mg/L and is improved by 126%. The method provided by the invention provides a new strategy for improving the yield of the fengycin and has practical application value and potential commercial value for realizing the industrial production of the fengycin.
Drawings
FIG. 1: electrophoresis results of the P43 amplified gene;
FIG. 2: electrophoresis results of the P43-sfp junction fragment;
FIG. 3: electrophoresis results of the P43-sfp-degQ junction fragment;
FIG. 4: a flow chart for constructing a gene expression vector module pHP 13-P43-sfp-degQ;
FIG. 5: constructing a flow chart of an accA, cypC and gapA three-gene overexpression plasmid pHY300 ACG;
FIG. 6: comparison graph of BSP003 fengogen yield of artificial strain BSP000 and gene engineering strain.
Detailed Description
In order to make the objects, technical solutions and effects of the present invention clearer, the following detailed description of the present invention is given with reference to the accompanying drawings and specific examples, which are illustrative and not restrictive, and modifications and variations can be made thereto by those skilled in the art according to the spirit of the present invention, and these modifications and variations should be construed as being within the scope of the present invention, which is defined by the claims.
The first embodiment is as follows: construction of Fenogen synthetic Strain BSP000
(1) Design and synthesis of P43 promoter amplification primer. According to the nucleotide sequence of the P43 promoter, the nucleotide sequence is shown as SEQ ID NO:1, the amplification primers are designed as follows (the lower line represents the enzyme cutting site), and the primers are synthesized by Scirpus Biotech limited.
P43-F1:CCCAAGCTTGCGGCTTCCTTGTAGAGCTCAGC(HindⅢ)
P43-R1:
CGCGGATCCCTCGAGACGCGTGCATGCTCTAGAAGATCTCTGCAGGTCGACCATGTGTACATTCCTCTC(BamHⅠ)
(2) And (3) extracting a bacillus subtilis 168 genome. Collecting 3-5mL of overnight cultured bacillus subtilis liquid in a centrifuge tube, centrifuging at 12000rpm for 1min, discarding supernatant, and collecting thallus precipitate. Adding 1mL of sterile water into the centrifuge tube, suspending and precipitating, centrifuging at 12000rpm for 1min, discarding supernatant, and repeatedly washing for 2-3 times. Add 100. mu.L of cell wall-breaking buffer, resuspend the cells, and vortex for 3 min. Weigh in 0.2g quartz sand, add 200 μ L phenol: chloroform: isopentanol (25:24:1) was vortexed thoroughly for 3min to disrupt the bacterial cells. Add 10. mu.L of 10 XTE buffer to the centrifuge tube and vortex well for 3 min. Centrifuge at 12000rpm for 5min and take the supernatant into another clean sterile centrifuge tube. Adding 900 μ L of anhydrous ethanol and 20 μ L of 3M sodium acetate solution into the supernatant, mixing, and standing at room temperature for more than 30 min. Centrifuging at 12000rpm for 10min, discarding supernatant, and collecting the precipitate at the bottom of the centrifuge tube. The pellet was washed with 500. mu.L of 70% ethanol, gently pipetted, and then centrifuged at 12000rpm for 1 min. The precipitate was washed with 500. mu.L of 70% ethanol, gently whipped, and then centrifuged at 12000rpm for 10min, and the precipitate was collected and dried on a 55 ℃ metal bath until no alcohol smell was observed. The precipitate was dissolved with double distilled water preheated in advance in a 55 ℃ metal bath and stored in a refrigerator at-20 ℃.
(3) Amplification of the P43 promoter (the amplification results are shown in FIG. 1). The P43 promoter was amplified using the extracted Bacillus subtilis 168 genome as a template and the above-mentioned P43-F1 and P43-R1 as primers. The PCR reaction system is as follows: total volume 50. mu.L, sterile water 16. mu.L, 2 × Phanta Max Buffer 25. mu.L, dNTP Mix 1. mu.L, upstream primer 2. mu.L, downstream primer 2. mu.L, Phanta Max Super Fidelity DNA Polymerase 1. mu.L, template 3. mu.L; the PCR reaction program is: 95 ℃ for 3min, 95 ℃ for 15s, 72 ℃ for 60s/kb, 72 ℃ for 5min, 4 ℃ incubation, cycle number: 30.
(4) designing and synthesizing sfp gene amplification primers. According to the nucleic acid sequence of sfp gene, the nucleotide sequence is shown as SEQ ID NO:2, the amplification primers are designed as follows (the lower straight line represents the enzyme cutting site), and the primers are synthesized by Scenario Biotech, Inc.
sfp-F:GCGTCGACCCAAGGAGGGTATAGCTATGAAAATTTACGGAGTATATATG(SalⅠ)
sfp-R:GAAGATCTTTATAACAGCTCTTCATACGTTTTC(BglⅡ)
(5) Extraction of Bacillus amyloliquefaciens FZB42 genome. Collecting 3-5mL of overnight cultured bacillus amyloliquefaciens bacterial liquid in a centrifuge tube, centrifuging at 12000rpm for 1min, discarding supernatant, and collecting bacterial precipitates. Adding 1mL of sterile water into the centrifuge tube, suspending and precipitating, centrifuging at 12000rpm for 1min, discarding supernatant, and repeatedly washing for 2-3 times. Add 100. mu.L of cell wall-breaking buffer, resuspend the cells, and vortex for 3 min. Weigh in 0.2g quartz sand, add 200 μ L phenol: chloroform: isopentanol (25:24:1) was vortexed thoroughly for 3min to disrupt the bacterial cells. Add 10. mu.L of 10 XTE buffer to the centrifuge tube and vortex well for 3 min. Centrifuge at 12000rpm for 5min and take the supernatant into another clean sterile centrifuge tube. Adding 900 μ L of anhydrous ethanol and 20 μ L of 3M sodium acetate solution into the supernatant, mixing, and standing at room temperature for more than 30 min. Centrifuging at 12000rpm for 10min, discarding supernatant, and collecting the precipitate at the bottom of the centrifuge tube. The pellet was washed with 500. mu.L of 70% ethanol, gently pipetted, and then centrifuged at 12000rpm for 1 min. The precipitate was washed with 500. mu.L of 70% ethanol, gently whipped, and then centrifuged at 12000rpm for 10min, and the precipitate was collected and dried on a 55 ℃ metal bath until no alcohol smell was observed. The precipitate was dissolved with double distilled water preheated in advance in a 55 ℃ metal bath and stored in a refrigerator at-20 ℃.
(6) And (3) amplification of sfp gene. And (3) amplifying the sfp gene by using the extracted bacillus amyloliquefaciens FZB42 genome as a template and the sfp-F and the sfp-R as primers. The PCR reaction system is as follows: total volume 50. mu.L, sterile water 16. mu.L, 2 × Phanta Max Buffer 25. mu.L, dNTP Mix 1. mu.L, upstream primer 2. mu.L, downstream primer 2. mu.L, Phanta Max Super Fidelity DNA Polymerase 1. mu.L, template 3. mu.L; the PCR reaction program is: 95 ℃ for 3min, 95 ℃ for 15s, 72 ℃ for 60s/kb, 72 ℃ for 5min, 4 ℃ incubation, cycle number: 30.
(7) design and synthesis of primers for amplification of the degQ gene. According to the nucleotide sequence of the degQ gene, the nucleotide sequence is shown as SEQ ID NO:3, the amplification primers are designed as follows (the lower straight line represents the enzyme cutting site), and the primers are synthesized by Scirpus Biotech limited.
degQ-F:GAAGATCTCCAAGGAGGGTATAGCTATGGAAAAGAAACTTGAAGAAG(BglⅡ)
degQ-R:CGGAATTCTTTCTCCTTGATCCGGACAGAATC(EcoRⅠ)
(8) Amplification of the degQ gene. And (3) amplifying the degQ gene by using the extracted bacillus subtilis 168 genome as a template and the degQ-F and the degQ-R as primers. The PCR reaction system is as follows: total volume 50. mu.L, sterile water 16. mu.L, 2 × Phanta Max Buffer 25. mu.L, dNTP Mix 1. mu.L, upstream primer 2. mu.L, downstream primer 2. mu.L, Phanta Max Super Fidelity DNA Polymerase 1. mu.L, template 3. mu.L; the PCR reaction program is: 95 ℃ for 3min, 95 ℃ for 15s, 72 ℃ for 60s/kb, 72 ℃ for 5min, 4 ℃ incubation, cycle number: 30.
(9) the process and screening of recombinant plasmid pHP13-P43-sfp-degQ are constructed by connecting P43 promoter, sfp and degQ gene to pHP13 plasmid. As shown in FIG. 4, the P43 promoter fragment in (8) was digested with restriction enzymes Hind III and BamH I, plasmid pHP13 was also digested with Hind III and BamH I, and the gene fragment containing the cleaved ends was enzymatically ligated with plasmid pHP13 containing the same cleaved ends using T4 ligase. The sfp and degQ genes were ligated in the same manner in this order to a plasmid containing P43 promoter (the amplification results of P43-sfp after the sfp gene ligation are shown in FIG. 2, and the amplification results of P43-sfp-degQ after the degQ gene ligation are shown in FIG. 3). And transforming the ligation product into a large intestine DH5 alpha competence, coating the ligation product in an LB solid culture medium (LB solid culture medium formula: 10g/L peptone, 5g/L yeast powder, 10g/L sodium chloride and 16g/L agar) containing 5 mu g/mL chloramphenicol, culturing at 37 ℃ for 16-18 hours, selecting a single colony growing out, carrying out colony PCR verification, and screening out a correct double-gene vector pHP13-P43-sfp-degQ after the verification that the size of the fragment is consistent with that of a theoretical fragment. Liquid amplification culture is carried out on the single colony which is correctly obtained, and the extracted plasmid is sent to the department of biotechnology limited company for sequencing verification.
(10) Introducing an expression plasmid pHP13-P43-sfp-degQ into an original strain of the bacillus subtilis 168 in a transformation mode, coating the original strain on a chloramphenicol screening pressure plate for solid plate culture, performing inverted standing culture at 37 ℃ for 12-14h, selecting a single colony with a large diameter for verification, screening out a correct zygote, extracting a plasmid for verification, and finally obtaining an initial artificial strain of the bacillus subtilis 168 capable of producing the fengycin, which is named as BSP 000.
Example two: construction of Fengyin high-producing strain BSP003
(1) Aiming at the BSP000 strain, collecting all gene-protein-reaction information of the strain from a database, constructing a genome scale network metabolic model of the BSP000 strain after optimization such as filling deletion reaction, removing redundant reaction and the like, and simulating three gene overexpression targets of accA, cypC and gapA by utilizing a Flux Balance Analysis (FBA) and a minimum metabolic adjustment (MOMA) algorithm.
(2) Design and synthesis of P43 promoter, accA, cypC and gapA gene amplification primers. Amplification primers were designed based on the nucleic acid sequences of accA gene (nucleotide sequence shown by SEQ ID NO: 5), cypC gene (nucleotide sequence shown by SEQ ID NO: 6) and gapA gene (nucleotide sequence shown by SEQ ID NO: 7), respectively (the lower straight line indicates the cleavage site), and the primers were synthesized by Scutellaria Biotech Co., Ltd.
P43-F2:CCAAGCTTTGATAGGTGGTATGTTTTCGCT(HindⅢ)
P43-R2:CGGATCCCAGTCTAGACACCTCGAGGCGAGATCTCATGTGTACATTC(BamHⅠ)
accA-F:GAAGATCTCCAAGGAGGGTATAGCTGTGGCTCCAAGATTAGAATTTG(BglⅡ)
accA-R:CCGCTCGAGTTAGTTTACCCCGATATATTG(XhoⅠ)
cypC-F:CGCTCGAGCCAAGGAGGGTATAGCTATGAATGAGCAGATTCCACATG(XhoⅠ)
cypC-R:GCTCTAGATTAACTTTTTCGTCTGATTCCG(XbaⅠ)
gapA-F:GCTCTAGACCAAGGAGGGTATAGCTATGGCAGTAAAAGTCGGTATT(XbaⅠ)
gapA-R:CGGGATCCTTAAAGACCTTTTTTTGCGATG(BamHⅠ)
(3) Amplification of the P43 promoter, accA, cypC and gapA genes. The extracted Bacillus subtilis 168 genome is used as a template, and the P43-F2, P43-R2, accA-F, accA-R, cypC-F, cypC-R, gapA-F and gapA-R are used as primers to amplify the P43 promoter, accA, cypC and gapA genes. The PCR reaction system is as follows: total volume 50. mu.L, sterile water 16. mu.L, 2 × Phanta Max Buffer 25. mu.L, dNTP Mix 1. mu.L, upstream primer 2. mu.L, downstream primer 2. mu.L, Phanta Max Super Fidelity DNA Polymerase 1. mu.L, template 3. mu.L; the PCR reaction program is: 95 ℃ for 3min, 95 ℃ for 15s, 72 ℃ for 60s/kb, 72 ℃ for 5min, 4 ℃ incubation, cycle number: 30.
(4) the process and screening of recombinant plasmid pHY300ACG constructed by sequentially linking the P43 promoter, accA, cypC and gapA genes to pHY300PLK plasmid (the nucleotide sequence is shown in SEQ ID NO: 8). The construction scheme is shown in FIG. 5, the P43 promoter fragment in (3) is digested with restriction enzymes Hind III and BamH I, plasmid pHY300PLK is also digested with Hind III and BamH I, and the gene fragment containing the cleaved ends is enzymatically ligated with plasmid pHP13 containing the same cleaved ends using T4 ligase. The accA, cypC and gapA genes were ligated in the same manner in sequence to a plasmid containing the P43 promoter. And transforming the ligation product into a large intestine DH5 alpha competence, coating the ligation product in an LB solid culture medium (LB solid culture medium formula: 10g/L peptone, 5g/L yeast powder, 10g/L sodium chloride and 16g/L agar) containing 100 mu g/mL ampicillin, culturing at 37 ℃ for 16-18 hours, selecting a single colony growing out, carrying out colony PCR verification, and verifying that the size of the fragment accords with the size of a theoretical fragment, namely screening out a correct three-gene vector pHY300 PLK. Liquid amplification culture is carried out on the single colony which is correctly obtained, and the extracted plasmid is sent to the department of biotechnology limited company for sequencing verification.
(10) Introducing an expression plasmid pHY300PLK into a bacillus subtilis BSP000 original strain in a mode of transformation, coating the strain on a chloramphenicol and tetracycline screening pressure plate for solid plate culture, performing inverted standing culture at 37 ℃ for 12-14h, selecting a single colony with a large diameter for verification, screening out a correct zygote, extracting a plasmid for verification, and finally obtaining the bacillus subtilis strain capable of efficiently producing the toyoxin, wherein the bacillus subtilis strain is named as BSP 003.
Example three: culture and fermentation of BSP000 and BSP003 strains
(1) The components of the culture medium:
seed culture medium: 10g/L of tryptone, 5g/L of yeast extract powder, 10g/L of NaCl and 7.0 of pH;
fermentation medium: glucose 20g/L, peptone 20g/L, MgSO4·7H2O 0.5g/L,Na2HPO4·2H2O 0.4g/L,NaH2PO4 0.154g/L,pH 7.2~7.4。
(2) Culturing and fermenting BSP000 and BSP003 strains. Respectively inoculating the fengycin synthetic strain BSP000 and the fengycin high-yield strain BSP003 of the invention to an LB liquid culture medium at 37 ℃ for activation culture for 12-14h, taking a bacterial liquid to continuously perform solid plate culture, reversing and standing the bacterial liquid at 37 ℃ for culture for 16h, taking a bacterial colony with a larger diameter, performing seed culture in a seed culture medium with a liquid containing 50mL of liquid, culturing the bacterial colony at 37 ℃ and 220rpm/min for 12h to obtain a seed liquid, inoculating the seed liquid into a fermentation culture medium with an inoculation amount of 8.5% in volume ratio, fermenting at 37 ℃ and 190rpm/min, taking 30mL of fermentation liquid in a sterilized and dried 50mL special centrifuge tube at 48h, centrifuging at 8000rpm for 30min, collecting a supernatant, adjusting the pH to 2 by 6M HCl, standing in a refrigerator at 4 ℃ for 24h, centrifuging at 8000rpm for 30min after complete precipitation, collecting the precipitate, extracting the precipitate by using 5mL of methanol, adjusting the pH to 7.0, standing at 4 ℃ for 12h, the product is filtered by a 0.22 mu m oil film and then is used for the yield analysis of liquid chromatogram; liquid chromatograph 1100(Agilent, USA), column type: XDB C-18 reverse phase column (250 mm. times.4.6 mm, 5 μm), mobile phase: v (acetonitrile): v (water): v (trifluoroacetic acid) ═ 50: 50: 0.5, 0.8mL/min, 30 ℃, 210nm, and 20 muL of sample injection. The detection result of the fermentation yield is shown in fig. 6, the BSP000 can be produced to 26.44mg/L by the method provided by the invention, and the synthesis of the fengycin is realized; the yield of the fengycin of BSP003 is 59.87mg/L, which is increased by 126 percent compared with BSP 000.
The method provided by the invention provides a new strategy for improving the yield of the fengycin, and has practical application value and potential commercial value in the industrial production of the fengycin.
While the methods and techniques of the present invention have been described in terms of preferred embodiments, it will be apparent to those of ordinary skill in the art that variations and/or modifications of the methods and techniques described herein may be made without departing from the spirit and scope of the invention. It is expressly intended that all such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and content of the invention.
Sequence listing
<110> Tianjin university
<120> construction method for converting high-yield bacterial strain of fengycin by using glucose
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 354
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
gcggcttcct tgtagagctc agcattattg agtggatgat tatattcctt ttgataggtg 60
gtatgttttc gcttgaactt ttaaatacag ccattgaaca tacggttgat ttaataactg 120
acaaacatca ccctcttgct aaagcggcca aggacgctgc cgccggggct gtttgcgttt 180
ttgccgtgat ttcgtgtatc attggtttac ttattttttt gccaaagctg taatggctga 240
aaattcttac atttatttta catttttaga aatgggcgtg aaaaaaagcg cgcgattatg 300
taaaatataa agtgatagcg gtaccattat aggtaagaga ggaatgtaca catg 354
<210> 2
<211> 675
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
atgaaaattt acggagtata tatggaccgc ccgctttctg caggggaaga ggatcggatg 60
atggcggccg tgtccgccga aaagcgggaa aaatgccggc gcttttacca taaggaggat 120
gctcaccgca ccttgatcgg cgacatgctg atccgcaccg ctgcggcgaa ggcttatgga 180
cttgatccgg ccgggatttc attcggcgtc caggaatacg gaaagccgta catccccgcg 240
cttccggaca tgcactttaa catttcccac tccgggcgct ggatcgtgtg cgccgttgat 300
tcaaaaccga tcggcattga tattgaaaaa atgaagcccg gcacaattga tatcgccaaa 360
cggttttttt cgccgacgga atacagtgat ctgcaagcga aacaccccga tcagcagacc 420
gattattttt accacctgtg gtcgatgaaa gaaagcttta tcaagcaggc cggaaaaggg 480
ctttccctgc cgcttgattc attcagcgtc cgccttaaag acgacggcca tgtgtccatt 540
gagctcccgg acggacatga accttgtttc atccgcacat atgaggcgga cgaggagtat 600
aagctggccg tttgtgcggc gcatcccgat ttttgtgacg ggattgagat gaaaacgtat 660
gaagagctgt tataa 675
<210> 3
<211> 325
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
atggaaaaga aacttgaaga agtaaaacaa ttgttattcc gactcgaact tgatattaaa 60
gaaacgacag attcattacg aaacattaac aaaagcattg atcaactcga taaatacaat 120
tatgcaatga aaatttcgtg aaaaagactt ggaaacaagt cttttttttc gttctaccga 180
tacaataaat ggataaagta ttatatgatt gttaaaaaac gaaaaacctg ctgtccttta 240
aatgtcccat ttagtaaaat ggaatgggag gggggaagtc gttattgagc agatatgttt 300
agattctgtc cggatcaagg agaaa 325
<210> 4
<211> 4748
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
tatattttat aggattggtt tttaggaaat ttaaactgca atatatcctt gtttaaaact 60
tggaaattat cgtgatcaac aagtttattt tctgtagttt tgcataattt atggtctatt 120
tcaatggcag ttacgaaatt acacctcttt actaattcaa gggtaaaatg gccttttcct 180
gagccgattt caaagatatt atcatgttca tttaatctta tatttgtcat tattttatct 240
atattatgtt ttgaagtaat aaagttttga ctgtgtttta tatttttctc gttcattata 300
accctcttta atttggttat atgaattttg cttattaacg attcattata accacttatt 360
ttttgtttgg ttgataatga actgtgctga ttacaaaaat actaaaaatg cccatatttt 420
ttcctcctta taaaattagt ataattatag cacgaaaagg atctaggtga agatcctttt 480
tgataatctc atgaccaaaa tcccttaacg tgagttttcg ttccactgag cgtcagaccc 540
cgtagaaaag atcaaaggat cttcttgaga tccttttttt ctgcgcgtaa tctgctgctt 600
gcaaacaaaa aaaccaccgc taccagcggt ggtttgtttg ccggatcaag agctaccaac 660
tctttttccg aaggtaactg gcttcagcag agcgcagata ccaaatactg ttcttctagt 720
gtagccgtag ttaggccacc acttcaagaa ctctgtagca ccgcctacat acctcgctct 780
gctaatcctg ttaccagtgg ctgctgccag tggcgataag tcgtgtctta ccgggttgga 840
ctcaagacga tagttaccgg ataaggcgca gcggtcgggc tgaacggggg gttcgtgcac 900
acagcccagc ttggagcgaa cgacctacac cgaactgaga tacctacagc gtgagctatg 960
agaaagcgcc acgcttcccg aagggagaaa ggcggacagg tatccggtaa gcggcagggt 1020
cggaacagga gagcgcacga gggagcttcc agggggaaac gcctggtatc tttatagtcc 1080
tgtcgggttt cgccacctct gacttgagcg tcgatttttg tgatgctcgt caggggggcg 1140
gagcctatgg aaaaacgcca gcaacgcggc ctttttacgg ttcctggcct tttgctggcc 1200
ttttgctcac atgttctttc ctgcgttatc ccctgattct gtggataacc gtattaccgc 1260
ctttgagtga gctgataccg ctcgccgcag ccgaacgacc gagcgcagcg agtcagtgag 1320
cgaggaagcg gaagagcgcc caatacgcaa accgcctctc cccgcgcgtt ggccgattca 1380
ttaatgcagc tggcacgaca ggtttcccga ctggaaagcg ggcagtgagc gcaacgcaat 1440
taatgtgagt tagctcactc attaggcacc ccaggcttta cactttatgc ttccggctcg 1500
tatgttgtgt ggaattgtga gcggataaca atttcacaca ggaaacagct atgaccatga 1560
ttacgccaag cttggctgca ggtcgacgga tccccgggaa ttcactggcc gtcgttttac 1620
aacgtcgtga ctgggaaaac cctggcgtta cccaacttaa tcgccttgca gcacatcccc 1680
ctttcgccag ctggcgtaat agcgaagagg cccgcaccga tcgcccttcc caacagttgc 1740
gcagcctgaa tggcgaatgg cgactaacgg ggcaggttag tgacattaga aaaccgactg 1800
taaaaagtac agtcggcatt atctcatatt ataaaagcca gtcattaggc ctatctgaca 1860
attcctgaat agagttcata aacaatcctg catgataacc atcacaaaca gaatgatgta 1920
cctgtaaaga tagcggtaaa tatattgaat tacctttatt aatgaatttt cctgctgtaa 1980
taatgggtag aaggtaatta ctattattat tgatatttaa gttaaaccca gtaaatgaag 2040
tccatggaat aatagaaaga gaaaaagcat tttcaggtat aggtgttttg ggaaacaatt 2100
tccccgaacc attatatttc tctacatcag aaaggtataa atcataaaac tctttgaagt 2160
cattctttac aggagtccaa ataccagaga atgttttaga tacaccatca aaaattgtat 2220
aaagtggctc taacttatcc caataaccta actctccgtc gctattgtaa ccagttctaa 2280
aagctgtatt tgagtttatc acccttgtca ctaagaaaat aaatgcaggg taaaatttat 2340
atccttcttg ttttatgttt cggtataaaa cactaatatc aatttctgtg gttatactaa 2400
aagtcgtttg ttggttcaaa taatgattaa atatctcttt tctcttccaa ttgtctaaat 2460
caattttatt aaagttcatt tgatatgcct cctaaatttt tatctaaagt gaatttagga 2520
ggcttacttg tctgctttct tcattagaat caatcctttt ttaaaagtca atattactgt 2580
aacataaata tatattttaa aaatatccca ctttatccaa ttttcgtttg ttgaactaat 2640
gggtgcttta gttgaagaat aaaagaccac attaaaaaat gtggtctttt gtgttttttt 2700
aaaggatttg agcgtagcga aaaatccttt tctttcttat cttgatacta tatagaaaca 2760
acatcatttt tcaaaattag gtcaaagcct tgtgtatcaa gggtttgatg gttctttgac 2820
aggtaaaaac tccttctgct attattaagg tgtcgaatca aaataataga atgctagaga 2880
actagctcag aaggagtttt tttgttgatt tattcatctg aaaatgatta tagcatcctc 2940
gaagataaaa ccgcaacagg taaaaagcgg gattggaagg ggaaaaagag acggacgaac 3000
ctcatggcgg agcattacga agcgttagag agtaagattg gggcacctta ctatggcaaa 3060
aaggctgaaa aactaattag ttgtgcagag tatctttcgt ttaagagaga cccggagacg 3120
ggcaagttaa aactgtatca agcccatttt tgtaaagtga ggttatgtcc gatgtgtgcg 3180
tggcgcaggt cgttaaaaat tgcttatcac aataagttga tcgtagagga agccaataga 3240
cagtacggct gcggatggat ttttctcacg ctgacgattc gaaatgtaaa gggagaacgg 3300
ctgaagccac aaatttctgc gatgatggaa ggctttagga aactgttcca gtacaaaaaa 3360
gtaaaaactt cggttcttgg atttttcaga gctttagaga ttaccaaaaa tcatgaagaa 3420
gatacatatc atcctcattt tcatgtgttg ataccagtaa ggaaaaatta ttttgggaaa 3480
aactatatta agcaggcgga gtggacgagc ctttggaaaa aggcgatgaa attggattac 3540
actccaattg tcgatattcg tcgagtgaaa ggtaaagcta agattgacgc tgaacagatt 3600
gaaaacgatg tgcggaacgc aatgatggag caaaaagctg ttctcgaaat ctctaaatat 3660
ccggttaagg atacggatgt tgtgcgcggt aataaggtga ctgaagacaa tctgaacacg 3720
gtgctttact tggatgatgc gttggcagct cgaaggttaa ttggatacgg tggcattttg 3780
aaggagatac ataaagagct gaatcttggt gatgcggagg acggcgatct ggtcaagatt 3840
gaggaagaag atgacgaggt tgcaaatggt gcatttgagg ttatggctta ttggcatcct 3900
ggcattaaaa attacataat caaataaaaa aagcagacct ttagaaggcc tgctttttta 3960
actaacccat ttgtattgtg ttgaaatatg ttttgtatgg tgcactctca gtacaatctg 4020
ctctgatgcc gcatagttaa gccagccccg acacccgcca acacccgctg acgcgccctg 4080
acgggcttgt ctgctcccgg catccgctta cagacaagct gtgaccgtct ccgggagctg 4140
catgtgtcag aggttttcac cgtcatcacc gaaacgcgcg agacgaaagg gcctcgtgat 4200
acgcctattt ttataggtta atgtcatgat aataatggtt tcttagcgat tcacaaaaaa 4260
taggcacacg aaaaacaagt taagggatgc agtttatgca tcccttaact tacttattaa 4320
ataatttata gctattgaaa agagataaga attgttcaaa gctaatattg tttaaatcgt 4380
caattcctgc atgttttaag gaattgttaa attgattttt tgtaaatatt ttcttgtatt 4440
ctttgttaac ccatttcata acgaaataat tatacttttg tttatctttg tgtgatattc 4500
ttgatttttt tctacttaat ctgataagtg agctattcac tttaggttta ggatgaaaat 4560
attctcttgg aaccatactt aatatagaaa tatcaacttc tgccattaaa agtaatgcca 4620
atgagcgttt tgtatttaat aatcttttag caaacccgta ttccacgatt aaataaatct 4680
cattagctat actatcaaaa acaattttgc gtattatatc cgtacttatg ttataaggta 4740
tattacca 4748
<210> 5
<211> 978
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
gtggctccaa gattagaatt tgaaaaaccg gtgattgaac tgcaaaccaa aatcgccgaa 60
ctaaaaaaat tcacccaaga ttccgatatg gatctaagtg cggaaatcga acggctcgaa 120
gaccgtctcg ctaagcttca ggatgatatt tacaaaaatt tgaagccgtg ggaccgggtt 180
caaatcgcgc gtctggcgga ccgtccgaca actcttgatt atatcgaaca cctgtttacc 240
gacttttttg aatgtcacgg agacagagcg tacggggacg atgaagccat tgtcggcggg 300
attgcgaagt tccacggcct ccctgtaacg gtaatcgggc atcagcgcgg caaagacacg 360
aaggaaaacc tagtccgcaa ttttgggatg ccgcatccag aaggctacag aaaagcgctt 420
cgtctgatga aacaggctga caaatttaac agaccaatta tctgttttat tgatacgaag 480
ggggcatacc ctggacgagc agctgaagaa agaggacaaa gtgaagctat tgccaaaaac 540
ctgtttgaga tggccggcct tcgagtgcct gttatctgca tcgtcattgg tgaaggcgga 600
agcggcggag cccttggtct gggtgtaggc aatcacttgc atatgctgga aaactctact 660
tattctgtta tttctccgga aggtgccgcg gcacttttat ggaaggactc cagtcttgct 720
aaaaaagcag cagaaacaat gaaaatcact gcgccggatt taaaagaatt aggtattata 780
gatcatatga ttaaagaagt aaaaggcgga gcgcaccatg atgtgaagct gcaggcaagc 840
tatatggacg aaacccttaa acaatcgtta aaaactttac tgaagctgag cgaagaagaa 900
ttagttcagc agcgttatga aaaatataaa gcaattggca aagtctcggt tgaagatcaa 960
tatatcgggg taaactaa 978
<210> 6
<211> 1254
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
atgaatgagc agattccaca tgacaaaagt ctcgataaca gtctgacact gctgaaggaa 60
gggtatttat ttattaaaaa cagaacagag cgctacaatt cagatctgtt tcaggcccgt 120
ttgttgggaa aaaactttat ttgcatgact ggcgctgagg cggcgaaggt gttttatgat 180
acggatcgat tccagcggca gaacgctttg cctaagcggg tgcagaaatc gctgtttggt 240
gttaatgcga ttcagggaat ggatggcagc gcgcatatcc atcggaagat gctttttctg 300
tcattgatga caccgccgca tcaaaaacgt ttggctgagt tgatgacaga ggagtggaaa 360
gcagcagtca caagatggga gaaggcagat gaggttgtgt tatttgaaga agcaaaagaa 420
atcctgtgcc gggtagcgtg ctattgggca ggtgttccgt tgaaggaaac ggaagtcaaa 480
gagagagcgg atgacttcat tgacatggtc gacgcgttcg gtgctgtggg accgcggcat 540
tggaaaggaa gaagagcaag gccgcgtgcg gaagagtgga ttgaagtcat gattgaagat 600
gctcgtgccg gcttgctgaa aacgacttcc ggaacagcgc tgcatgaaat ggcttttcac 660
acacaagaag atggaagcca gctggattcc cgcatggcag ccattgagct gattaatgta 720
ctgcggccta ttgtcgccat ttcttacttt ctggtgtttt cagctttggc gcttcatgag 780
catccgaagt ataaggaatg gctgcggtct ggaaacagcc gggaaagaga aatgtttgtg 840
caggaggtcc gcagatatta tccgttcggc ccgtttttag gggcgcttgt caaaaaagat 900
tttgtatgga ataactgtga gtttaagaag ggcacatcgg tgctgcttga tttatatgga 960
acgaaccacg accctcgtct atgggatcat cccgatgaat tccggccgga acgatttgcg 1020
gagcgggaag aaaatctgtt tgatatgatt cctcaaggcg gggggcacgc cgagaaaggc 1080
caccgctgtc caggggaagg cattacaatt gaagtcatga aagcgagcct ggatttcctc 1140
gtccatcaga ttgaatacga tgttccggaa caatcactgc attacagtct cgccagaatg 1200
ccatcattgc ctgaaagcgg cttcgtaatg agcggaatca gacgaaaaag ttaa 1254
<210> 7
<211> 1008
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
atggcagtaa aagtcggtat taacggtttt ggtcgtattg gacgtaacgt attccgcgca 60
gcattaaaca atcctgaagt tgaggtagta gcggttaacg atttaacaga tgctaacatg 120
ctggctcacc ttttacaata tgattctgta cacggaaaat tagacgctga agtttcagtt 180
gacggtaaca accttgttgt taacggcaaa acaattgaag tttctgcaga acgcgatcct 240
gctaaactta gctggggcaa acaaggcgtt gaaatcgtag ttgaatctac tggtttcttc 300
acaaaacgcg cagacgctgc gaaacactta gaagctggcg cgaaaaaagt aatcatctct 360
gctcctgcta acgaagaaga tatcacaatc gttatgggtg ttaacgaaga taaatacgat 420
gcggctaacc acgatgttat ctctaacgca tcttgcacaa caaactgcct tgcgccgttt 480
gcaaaagtac ttaacgataa attcggcatc aaacgcggta tgatgacaac tgttcactct 540
tacacaaacg atcagcaaat ccttgatctt ccgcacaaag actaccgtcg tgcgcgtgca 600
gcagctgaaa acatcatccc aacatcaact ggtgctgcta aagcagtttc tctagttctt 660
cctgaactaa aaggcaaact gaacggtgga gcaatgcgtg ttccaactcc aaacgtttct 720
ctagttgact tggttgctga actgaaccaa gaagtaacag ctgaagaagt aaacgcagct 780
cttaaagaag cggctgaagg cgaccttaaa ggaatccttg gctacagcga agagccatta 840
gtttctggcg actacaacgg aaacaaaaac tcttctacaa tcgatgctct ttctacaatg 900
gttatggaag gcagcatggt aaaagtaatc tcttggtacg ataacgaaag cggctactct 960
aaccgcgttg ttgaccttgc agcttacatc gcaaaaaaag gtctttaa 1008
<210> 8
<211> 3
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
Claims (10)
1. A construction method for converting a high-yield bacterial strain of fengycin by using glucose; is characterized by comprising the following steps
1) Designing PCR primers according to the known sequence of the P43 promoter gene, and amplifying the P43 promoter gene by taking the Bacillus subtilis 168 genome as a template;
2) designing a PCR primer according to the known sequence of the sfp gene, and amplifying the gene sfp by using a bacillus subtilis 168 genome as a template;
3) designing a PCR primer according to the known sequence of the degQ gene, and amplifying the gene degQ by taking the genome of the bacillus amyloliquefaciens FZB42 as a template;
4) the gene sfp and the gene degQ are connected in series with pHP13 plasmid through enzyme digestion enzyme to form a gene expression module pHP 13-P43-sfp-degQ;
5) transferring the recombinant gene expression module pHP13-P43-sfp-degQ constructed in the step 4) into an original strain of the bacillus subtilis 168 by a chemical conversion method to construct a strain BSP000 capable of synthesizing the fengycin by using glucose;
6) aiming at the BSP000 strain, collecting all gene-protein-reaction information of the strain from a database, and constructing a genome scale network metabolic model of the BSP000 strain after optimization such as supplementing deletion reaction, removing redundant reaction and the like;
7) calculating the network metabolism model constructed in the step 6) by using flux balance analysis and a minimum metabolism regulation algorithm to obtain three overexpression target genes of accA, cypC and gapA;
8) designing PCR primers according to known sequences of accA, cypC and gapA genes, and amplifying the genes accA, cypC and gapA by taking a bacillus subtilis 168 genome as a template;
9) the genes accA, cypC and gapA are connected with pHY300PLK plasmid in series through enzyme digestion to form a gene over-expression vector pHY300 ACG;
10) transferring the gene over-expression vector pHY300ACG constructed in the step 9) into a BSP000 strain by a chemical conversion method to obtain a BSP003 strain;
11) carrying out shake flask fermentation culture on the genetic engineering strain constructed in the step 10) by using a fermentation medium, and efficiently producing the fengyuan.
2. The method as claimed in claim 1, wherein the nucleotide sequence of the P43 promoter gene is SEQ ID NO. 1.
3. The method as claimed in claim 1, wherein the nucleotide sequence of sfp gene is SEQ ID NO 2.
4. The method as claimed in claim 1, wherein the nucleotide sequence of the degQ gene is SEQ ID NO. 3.
5. The method as claimed in claim 1, wherein the pHP13 plasmid has the nucleotide sequence of SEQ ID NO 4.
6. The method of claim 1, wherein the nucleotide sequence of accA gene is SEQ ID NO 5.
7. The method of claim 1, wherein the nucleotide sequence of the cypC gene is SEQ ID NO 6.
8. The method of claim 1, wherein the nucleotide sequence of gapA gene is SEQ ID NO 7.
9. The method of claim 1, wherein the pHY300PLK plasmid nucleotide sequence is SEQ ID NO 8.
10. The method of claim 1, wherein the fermentation medium is: glucose 20g/L, peptone 20g/L, MgSO4·7H2O 0.5g/L,Na2HPO4·2H2O 0.4g/L,NaH2PO4 0.154g/L,pH 7.2~7.4。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110560598.XA CN113265414B (en) | 2021-05-21 | 2021-05-21 | Construction method for converting high-yield bacterial strain of fengycin by using glucose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110560598.XA CN113265414B (en) | 2021-05-21 | 2021-05-21 | Construction method for converting high-yield bacterial strain of fengycin by using glucose |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113265414A true CN113265414A (en) | 2021-08-17 |
CN113265414B CN113265414B (en) | 2022-07-08 |
Family
ID=77232576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110560598.XA Expired - Fee Related CN113265414B (en) | 2021-05-21 | 2021-05-21 | Construction method for converting high-yield bacterial strain of fengycin by using glucose |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113265414B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113969258A (en) * | 2021-11-09 | 2022-01-25 | 天津大学 | Method for constructing bacillus subtilis artificial strain for converting arabinose into fengycin |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105602876A (en) * | 2016-01-18 | 2016-05-25 | 南京农业大学 | Surfactin and Plipastatin co-production bacillus subtilis strain and method for constructing same |
CN110951667A (en) * | 2019-12-30 | 2020-04-03 | 淮阴工学院 | Fenogen high-yield strain LPB-18N and breeding and application thereof |
CN111019948A (en) * | 2019-12-30 | 2020-04-17 | 淮阴工学院 | Fenjunsu anabolism regulation gene FenSr3 and application thereof |
-
2021
- 2021-05-21 CN CN202110560598.XA patent/CN113265414B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105602876A (en) * | 2016-01-18 | 2016-05-25 | 南京农业大学 | Surfactin and Plipastatin co-production bacillus subtilis strain and method for constructing same |
CN110951667A (en) * | 2019-12-30 | 2020-04-03 | 淮阴工学院 | Fenogen high-yield strain LPB-18N and breeding and application thereof |
CN111019948A (en) * | 2019-12-30 | 2020-04-17 | 淮阴工学院 | Fenjunsu anabolism regulation gene FenSr3 and application thereof |
Non-Patent Citations (1)
Title |
---|
李响等: "degQ和sfp提高芽孢杆菌泛革素产量及其机理研究", 《中国生物防治学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113969258A (en) * | 2021-11-09 | 2022-01-25 | 天津大学 | Method for constructing bacillus subtilis artificial strain for converting arabinose into fengycin |
Also Published As
Publication number | Publication date |
---|---|
CN113265414B (en) | 2022-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108102940B (en) | Industrial saccharomyces cerevisiae strain with XKS1 gene knocked out by CRISPR/Cas9 system and construction method | |
CN110117551B (en) | Saccharomyces cerevisiae engineering bacterium for producing valencene, and construction method and application thereof | |
CN100540667C (en) | Utilize rice-embryo milk cell to produce recombination human serum albumin as bio-reactor | |
CN101796193A (en) | Process for preparing enantiomerically enriched amines | |
CN113201536B (en) | Polynucleotide with promoter activity and application thereof in producing amino acid | |
CN108300671A (en) | One plant of common fermentation xylose and glucose is with an industrial strain of S.cerevisiae strain of high yield xylitol and ethyl alcohol and construction method | |
CN113265414B (en) | Construction method for converting high-yield bacterial strain of fengycin by using glucose | |
CN108753808A (en) | A kind of recombinant expression carrier, recombinant expression host and its method for synthesizing adenosine triphosphoric acid | |
CN113046355A (en) | Novel intermediate-temperature prokaryotic Argonaute protein PbAgo characterization and application | |
CN113308482B (en) | Tetrahydropyrimidine synthetic gene cluster from Yunnan tengcong and application thereof | |
CN112831484A (en) | T7-RNA polymerase mutant and application thereof | |
CN114672447B (en) | Bacterial strain with self-flocculation capability and preparation method and application thereof | |
CN113166770A (en) | Recombinant escherichia coli system, construction method thereof and application thereof in synthesis of alpha-1, 2-fucosylated oligosaccharide | |
CN112522169B (en) | Genetically engineered bacterium for high yield of bacillomycin L and construction method and application thereof | |
CN110184292B (en) | Method for improving yeast cell surface display functional Infliximab Fab fragment by utilizing molecular chaperone | |
KR101956042B1 (en) | Introducing method of l-dihydroxyphenylalanine in target protein | |
CN111088209B (en) | Recombinant clostridium butyricum for producing 1, 4-butanediol and construction method and application thereof | |
CN101250539A (en) | Method for preparing recombinant heat-proof beta-glucuronic acid enzyme | |
CN109872774B (en) | YESS-based method for analyzing protein interaction in prokaryote | |
CN107475272A (en) | One kind tool heat endurance and halophilic agarase | |
CN114015678A (en) | Aminopeptidase Amp0279 derived from Bacillus sphaericus C3-41 as well as recombinant strain and application thereof | |
KR20110090565A (en) | Useful vector for transformation of microalgae and microalgae transformed with the same | |
WO2020210833A1 (en) | Systems, methods and compositions for recombinant in vitro transcription and translation utilizing thermophilic proteins | |
CN108866091B (en) | Plasmid for improving squalene content of rhodopseudomonas palustris and preparation and use methods thereof | |
CN114807194B (en) | Method for improving protein expression efficiency in clostridium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220708 |
|
CF01 | Termination of patent right due to non-payment of annual fee |